IP Library Granted Patent US 8,788,046
Granted Patent B2
US 8,788,046 · App. 13/309,024 · Granted Jul 22, 2014

Systems and methods for the treatment of pain through neural fiber stimulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,788,046
App. No.
13/309,024
Granted
Jul 22, 2014
Kind
B2
Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

Claims (21)

1. A method comprising the step of:

electrically stimulating target efferent nerve fibers through an electrode inserted in-vivo to generate an action potential in the target efferent nerve fibers to active muscle fibers while avoiding generation of action potentials in non-target Type III and IV nerve fibers in an animal to reduce a perception of pain by the animal, through activation of the target efferent nerve fibers wherein the target efferent nerve fibers are located outside a central nervous system of the animal.

2. A method according to claim 1 , wherein the animal is a human.

3. A method according to claim 1 , wherein the target efferent nerve fibers are located between a neurological motor point and the central nervous system of the human.

4. A method according to claim 3 , wherein the target efferent nerve fibers comprise motor axons.

5. A method according to claim 4 , wherein the motor axons comprise Aα axons.

6. A method according to claim 5 , further comprising the step of activating extrafusal muscle fibers.

7. A method according to claim 4 , wherein the motor axons comprise Aγ axons.

8. A method according to claim 7 , further comprising the step of activating intrafusal muscle fibers.

9. A method according to claim 1 , further comprising the step of activating afferent nerve fibers.

10. A method according to claim 9 , wherein the afferent nerve fibers innervate neural receptors.

11. A method according to claim 10 , wherein the neural receptors are proprioceptors.

12. A method according to claim 9 , wherein the step of activating afferent nerve fibers results from a transduction of a physiological response to the step of electrically stimulating the target efferent nerve fibers.

13. A method according to claim 12 , wherein the physiological response is a contraction of muscle fibers.

14. A method according to claim 13 , wherein the muscle fibers are extrafusal muscle fibers.

15. A method according to claim 13 , wherein the muscle fibers are intrafusal muscle fibers.

16. A method of reducing a perception of pain by an animal of a hypersensitized portion of the animal nervous system, the method comprising the step of:

applying electrical stimulation to a least a portion of the nervous system through an electrode inserted in-vivo to generate an action potential in a target efferent nerve fiber to active muscle fibers while avoiding generation of an action potential in a non-target Type III and IV nerve fibers causing a reduction of perception of pain by the animal, wherein the applying step is performed for a predetermined treatment time, and further wherein the reduction of perception of pain occurs at least partially during the treatment time and at least a portion of the reduction of perception of pain is maintained after the end of the predetermined treatment time.

17. A method according to claim 16 , wherein the animal is a human and the portion of the nervous system comprises efferent nerve fibers located neurologically between and outside a neurological motor point and a central nervous system of the human.

18. A method according to claim 1 , wherein the electrical stimulation of the target efferent nerve fibers is bidirectional.

19. A method according to claim 1 , wherein the target efferent nerve fibers are located outside a neurological motor point.

Assignments (16)
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066416/0526 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066526/0025 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066415/0750 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066416/0282 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066416/0420 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE PROPERTIES LISTED IN THE SECURITY INTEREST PREVIOUSLY RECORDED AT REEL: 030518 FRAME: 0830. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 10, 2020
From: SPR THERAPEUTICS, LLC
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 052137/0516 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0721 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0676 →
CHANGE OF NAME Recorded Dec 6, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044716/0812 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044414/0575 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044715/0395 →
SECURITY INTEREST Recorded Sep 24, 2014
From: SPR THERAPEUTICS, LLC
To: OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 033809/0771 →
SECURITY AGREEMENT Recorded May 30, 2013
From: SPR THERAPEUTICS, LLC
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 030518/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2012
From: BENNETT, MARIA E.; BOGGS, JOSEPH W., II; GRILL, WARREN M.; CHAE, JOHN
To: SPR THERAPEUTICS, LLC
Reel/Frame 027985/0110 →